NeuroXess (company brief)
Official site → Shanghai, China
NeuroXess is a Shanghai-based BCI company mentioned in reporting about China’s push to build an implantable BCI industry.
Reported status (Wired)
Wired reports that:
-
NeuroXess’ CEO Phoenix Peng says the company has implanted six paralyzed patients
-
in three patients, the system was used to decode Chinese speech
-
in others, it enabled thought control of digital devices
-
Wired: “China Is Building a Brain-Computer Interface Industry” (policy + company quotes): https://www.wired.com/story/china-is-getting-serious-about-brain-computer-interfaces/
Why it’s worth tracking
China’s BCI ecosystem is increasingly driven by:
- centralized policy roadmaps (2027/2030 milestones)
- rapid trial starts
- building a local supply chain (chips, electrodes, decoding algorithms)
NeuroXess is one of the clearest named examples in mainstream reporting with multi-patient implant claims.
What to watch
-
Peer-reviewed publications / technical details Electrode type, channel count, implantation approach, and decoding pipeline.
-
Regulatory pathway What approvals exist now, and what is the path to a marketed medical device?
-
Performance metrics Accuracy, throughput, training time, stability over months.
Notes on sourcing
Draft. Current citations are primarily a Wired feature with quotes from company leadership. We should add primary sources (clinical registry entries, papers, institutional announcements) once we gather them.